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The invasive stages of Apicomplexa parasites, called
zoites, have been largely studied in in vitro systems, with
a special emphasis on their unique gliding and host cell
invasive capacities. In contrast, the means by which these
parasites reach their destination in their hosts are still
poorly understood. We summarize here our current
understanding of the cellular basis of in vivo parasitism
by two well-studied Apicomplexa zoites, the Toxoplasma
tachyzoite and the Plasmodium sporozoite. Despite
being close relatives, these two zoites use different
strategies to reach their goal and establish infection.
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Apicomplexa constitute a large phylum of parasitic proto-
zoa. Many are pathogenic to humans like Plasmodium,
the causative agent of malaria, and Toxoplasma, which
induces severe manifestations in immunocompromised
individuals, while others like Eimeria and Theileria cause
heavy losses in domestic animals and cattle. They are
obligate intracellular parasites that invade host cells by
developing into specialized stages called zoites. Zoites
have a conserved structure, being elongated and polarized
cells that secrete at their anterior tip the content of apically
located secretory organelles, named micronemes and
rhoptries (1). Zoites move on solid substrates by gliding,
without changing their overall shape (2), at the impressive
speed of several microns per second. This motility, which
is powered by a linear actomyosin motor located under-
neath the zoite plasma membrane (3,4), also allows zoite
invasion of host cells inside a so-called parasitophorous
vacuole (PV), a process that lasts only a few seconds.
Zoite entry inside a PV is typically followed by parasite
development and the generation of multiple new zoites.
Some but not all Apicomplexa zoites express a second,
more dramatic way to invade host cells by piercing
their plasma membrane and migrating through them (5).
Two of the three zoites of Plasmodium, the ookinete
and the sporozoite, traverse host cells, like sporozoites
of Toxoplasma and Eimeria. The Toxoplasma tachyzoite,
however, does not traverse host cells.
So far, most studies on Apicomplexa zoites have been
performedin vitro, focusing in particular on the Toxoplasma
tachyzoite and the Plasmodium sporozoite. These studies
have greatly boosted our molecular understanding of gliding
motility and of parasite interactions with cultured cells. In
contrast, we know little of how these zoites behave in their
hosts. We summarize below recent findings on the ways
by which the Toxoplasma tachyzoite and the Plasmodium
sporozoite traffic inside host tissues and across cellular
barriers to disseminate and establish infection.
The Toxoplasma Tachyzoite
Toxoplasma gondii is a water-/food-borne parasite that can
subvert any warm-blooded animal as host and cause
severe pathology (6). Following oral ingestion, the parasite
initially crosses the intestinal epithelium and disseminates
in numerous tissues including immunoprivileged sites
such as the central nervous system, the retina or a devel-
oping fetus. Infection is initiated either by the sporozoite
form, after ingestion of water/food contaminated by oo-
cysts from cat feces, or by the bradyzoite form, after
ingestion of cyst-containing raw meat. Both the sporozoite
and the bradyzoite forms are released from their enclos-
ing structures in the intestinal lumen, penetrate intestinal
epithelial cells and subsequently differentiate into the
rapidly replicating tachyzoite stage (Figure 1). The tachy-
zoites must then disseminate from the intestinal lamina
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they can further replicate inside cells and eventually
differentiate into the bradyzoite form, a quiescent parasite
stage as long as the immune system holds it in check
within a cyst.
The success of the tachyzoite essentially depends on its
ability to reach and cross endothelia from both lymphatic
and blood vessels. The tachyzoite dissemination is thought
to start by the infection of gut-associated secondary
lymphoid organs (7), and recent quantitative polymerase
chain reaction analysis supports the view that tachyzoites
traffic through the intestinal lymphatic vessels before
reaching the blood (8). At the other end of the blood
transport, tachyzoites cross blood endothelial barriers into
tissues, particularly the placenta in primo-parasitized preg-
nant females and the blood–brain and blood–retina bar-
riers, which lead to the most severe pathology. Since free
tachyzoites are known to survive several hours in serum-
containing medium and to invade virtually any nucleated
host cell type, the central question is whether they reach
their destination by using their own motility or by hijacking
host circulating leukocytes.
Traveling as an extracellular parasite
Evidence that tachyzoites can travel extracellularly to their
destination by an active process is mainly indirect. Type I
(RH) Toxoplasma strains, known to rapidly disseminate
and generate high tissue burdens in murine models, are
associated with a stronger migratory capacity, that is,
a greater proportion of gliding individuals moving longer
distances, compared with the less virulent type II and type
III strains (9). Type I tachyzoites better disseminate ex vivo
in mouse ileum explants, with more parasites entering the
lamina propria and penetrating the submucosa and in
some cases reaching the vascular endothelium (9,10).
They also more efficiently cross Madin Darby Canine
Kidney (MDCK)-polarized cells cultured as monolayers on
a transwell (11). In this system, free tachyzoites migrate
across monolayers by passing between cells, that is, using
a paracellular route. They gather mainly around intercellular
junctions and actively migrate across the cellular barrier
without altering its integrity. Migration between MDCK
cellswasalsoproposedtodependoninteractionsbetween
intercellular adhesion molecule 1 (ICAM-1) on host cell
surfaces and the parasite protein micronemal protein 2
(MIC2) (11), which links the membrane-associated motor
Figure 1: Schematics of in vivo infection by the Toxoplasma tachyzoite and the Plasmodium sporozoite. Left, the Toxoplasma
tachyzoite. Toxoplasma infection starts by the ingestion of oocysts or tissues cysts (1) that liberate in the intestinal lumen free sporozoites
or bradyzoites, respectively (2). Free parasites invade enterocytes (3), where they multiply and transform into tachyzoites, which are
released in the lamina propria of the intestine (4). Tachyzoites invade the endothelium of lymphatic vessels (5), are taken up by the lymph
(6), go through lymph nodes (7) and reach the blood circulation (8). Tachyzoites then cross blood endothelium barriers in immunoprivileged
organs (9), for example, the brain, the retina or the placenta, or in other organs (10), for example, muscles, where they invade host cells,
multiply and transform into dormant bradyzoites (11). Tachyzoites in the intestine may also cross the endothelium of blood vessels. Right,
the Plasmodium sporozoite. Sporozoites are formed inside oocysts (1) in the wall of the mosquito midgut, are released in the hemocele
bathed by the hemolymph (2), invade acinar cells (3) and exit in the secretory cavities (4) of the salivary glands and finally move into the
secretory ducts (5). In the mammalian host, sporozoites are deposited in the dermis (6). Sporozoites can invade the endothelium of
lymphaticvesselsinthedermis(7)and thenendupin theproximaldraininglymphnode(8),wheretheyare killed.Sporozoitescanremainin
the dermis (9), in which case their fate is unknown. They can invade the endothelium of blood vessels in the dermis (10), reach the liver,
cross the endothelium barrier of liver sinusoids (12) and invade hepatocytes (13), where they transform into merozoites, the erythrocyte-
infecting form of the parasite. Sporozoites in the blood can also reach other organs than the liver (11), for example, the spleen, where the
sporozoite fate is not well documented. BZ, bradyzoite; MZ, merozoite; SPZ, sporozoite; TZ, tachyzoite.
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contrast, tachyzoites did not appear to use a transcellular
route to cross the MDCK barrier, that is, they did not enter
cells apically and exit from the basolateral side.
Although it remains to be seen whether tachyzoites
interact with endothelial barriers, particularly from the
brain, in the same manner as they interact with MDCK
epithelial barriers, these data favor the view that tachy-
zoites might disseminate to distant tissues as extracellular
parasites by an active process. During parasite transmi-
gration, the interactions between MIC2, which contains an
I-domain, and ICAM-1 are reminiscent of the interactions
between I-domains of b2 leukocyte integrins and im-
munoglobulin folds present in many intercellular junctional
molecules during leukocyte diapedesis (13). However,
although such interactions typically mediate leukocyte
passage by a paracellular route, they also allow a trans-
cellular route of diapedesis by which leukocytes induce the
formation of and migrate through intracellular ‘transmigra-
tory cups’ across individual endothelial cells (14).
Hijacking motile leukocytes
More recent work suggests that the tachyzoite might also
subvert host cells to reach its destination. Tachyzoites are
known to actively penetrate various types of leukocytes
invitro(15,16)andtolocalizeinsideleukocytesinthemurine
intestine (8). It was shown recently (8) that following
intragastric delivery of parasite cysts in mice (i) tachyzoites
parasitize CD11cþ dendritic cells in the lamina propria of
the intestine and the mesenteric lymph nodes, suggesting
that these cells contribute to the early parasite dissemin-
ation from the intestinal wall; (ii) in the blood, parasites
associate with CD11bþ, most likely monocytes (rather
than B cells or neutrophils), but not CD11c  leukocytes;
(iii) the CD11cþ dendritic cells and the CD11bþ leukocytes
recovered from the mesenteric lymph nodes and the blood
of parasitized mice, respectively, can trigger the parasitic
process once intravenously transferred to naı ¨ve mice and
in both cases reach the brain and (iv) anti-CD11b blocking
antibodies prevent CD11bþ circulating leukocytes from
extravazating into tissues. This indicates that the parasit-
ized blood CD11bþ monocytes can migrate across the
blood–brain barrier and promote parasite entry in the brain.
Intriguingly, only single or paired tachyzoites were found to
be associated with the dendritic cells from the mesenteric
lymph nodes and the blood CD11bþ cells, while typical
intracellular rosettes indicative of dividing tachyzoites were
rarely seen associated with the shuttle cells (8). In most
cases, the single parasite seemed intracellular but local-
ized at the cell periphery and did not appear to be located
inside a typical PV. Rather, the intracellular but growth-
arrested parasite was wrapped within folds of the host
cell plasma membrane, in what could be a novel type of
interaction between the Toxoplasma tachyzoite and the
host cells (Figure 2). This transport interaction could
ensure that the parasite is shielded but does not start
replicating inside the shuttle cell and thus avoids its lysis
and death.
Figure 2: A pair of tachyzoites is associated with MHC-II positive cells in lymph nodes. A mouse was infected with cysts of the 76K
Toxoplasma gondii strain, mesenteric lymph nodes were recovered 5 days after infection, a cell suspension from the lymph node was
fixed, MHC class II molecules were detected using class II I-A
bdq and I-E
dk antibodies (green), the parasite surface was stained using anti-
SAG1 antibodies (red) and samples were observed by confocal microscopy (0.4-mm section). Note that the tachyzoites are located at the
periphery of the host cell and are surrounded by the plasma membrane of the host cell. MHC, major histocompatibility complex.
Traffic 2008; 9: 627–635 629
Migration of Apicomplexa Across Biological BarriersThere is also evidence that the hijackers alter the motile
properties of the shuttle leukocytes. In vivo, leukocyte
extravazation is sixfold greater in parasitized mice than in
nonparasitized mice (8). Bioluminescence in vivo imaging
also showed that mice inoculated with tachyzoite-loaded
dendritic cells suffered wide parasite dissemination and
developed dramatically higher parasite loads, including in
the brain, earlier than mice inoculated with free parasites
(17,18). In vitro, bone marrow-derived dendritic cells
containing tachyzoites exhibit significantly enhanced trans-
migration across endothelial cell monolayers in transwells,
while uninfected dendritic cells and tachyzoite-loaded
monocytes or fibroblasts do not. This induced hyper-
motility phenotype depends on the presence of live, not
phagocytosed parasites and is associated with an upregu-
lation of maturation markers and costimulatory molecules.
Manipulation of dendritic cells by the tachyzoites seems
specific because dendritic cells harboring tachyzoites do
not upregulate ICAM-1, unlike lipopolysaccharide-matured
dendritic cells, and slightly downregulate the CD11a and
CD18 integrin chains (17).
Therefore, these data support the concept that transport of
tachyzoites in migratory leukocytes contributes signifi-
cantly to their dissemination in vivo, in particular to the
brain. However, it remains unclear whether the CD11cþ
cells characterized in vitro (17) play a role in dissemination
in vivo because following parasite inoculation through the
natural route (8), infected CD11cþ cells were only found
in the secondary lymphoid organs and not in the blood.
In addition, dendritic cells infected in vitro (17) contained
rosettes, whereas the dendritic cells in vivo harbored only
single or paired parasites (8). However, the exact nature
of the interaction between the tachyzoite and its shuttle
cell, that is, surrounded by plasma membrane extensions
or truly internalized, awaits better characterization. Direct
visualization, possibly by two-photon microscopy, of
blood–brain barrier crossing events should be decisive in
determining the leukocyte subpopulation that effectively
shuttles tachyzoites to the brain.
The Plasmodium Sporozoite
The life of the Plasmodium sporozoite is a perilous odyssey
from its site of birth, the midgut wall of an Anopheline
mosquito, to its destination, a hepatocyte in a mammalian
host (Figure 1). There, the sporozoite finally settles to
generate tens of thousands of merozoites, the parasite
form that is adapted to erythrocytes and initiates the
pathogenic replication cycles. To reach the hepatocyte, the
sporozoite relies on two basic abilities: a vigorous gliding
motility and an aggressive cell transmigration behavior.
Marathon man
Much direct evidence has accumulated in the past few
years indicating that the Plasmodium sporozoite remains
extracellular during most of its journey and locomotes
through its own active motility and passive transport in the
fluids of its hosts. In the mosquito, although sporozoites
need not be motile for leaving the oocyst and reaching the
hemolymph, active motility is needed for penetrating the
secretory cells of the salivary glands and reaching the
extracellular secretory cavities (19). Sporozoites also move
by gliding inside salivary cavities and ducts and apparently
need to access the ducts to be ejected during salivation
(20). During the mosquito bite, most sporozoites are
inoculated into the dermis of the mammal (21,22), as
mosquitoes inject saliva while probing the skin, before
ingesting blood. Imaging Plasmodium berghei sporozoites
in the mouse ear has shown the strong, tortuous and
apparently random motility of the few individuals immedi-
ately after inoculation (23,24). The duration of sporozoite
active motility appears to be greater in vivo than in vitro
and might also vary with the parasite species; while
P. berghei sporozoites are no longer motile after 2 h (24),
Plasmodium yoelii sporozoites trickle out from the skin into
the blood for hours after the mosquito bite (25,26).
Sporozoites also glide beyond the dermis, including along
endothelial surfaces inside dermal blood vessels (27),
inside the lymph node (24) and in the sinusoids and the
liver parenchyma (28,29).
The picture of the Plasmodium pre-erythrocytic phase that
emerges from intravital imaging studies is more complex
than the traditional viewof all injected sporozoites traveling
from the skin to the liver through the blood (Figure 1).
Instead, the skin phase of the sporozoite’s life appears to
act as a crossroad, the dermal sporozoites having three
possible fates; (i) they can invade blood capillaries in the
dermis (23,24) and reach the liver, where they invade
hepatocytes; (ii) they can invade lymphatic vessels in the
dermis (24), in which case they do not end up in the liver,
as had been hypothesized (30,31), but stop their journey in
the proximal lymph node, where most parasites are
eventually degraded inside dendritic cells (24) and (iii) they
can be left in the dermis after cessation of their active
motility, and the fate of the sporozoites left in the dermis
remains to be characterized (24,32). Although this picture
results from studies on rodent-infecting Plasmodium spe-
cies, the original observation by Boyd and Kitchen (21) of
a Plasmodium vivax sporozoite in a draining lymph node
24 h after sporozoite injection by a mosquito suggests that
human- and rodent-infecting sporozoites might behave
similarly in their respective host.
Crossing endothelial barriers in the skin:
which way in?
Little is known of how sporozoites cross endothelial
barriers. Intravital imaging shows that sporozoites are able
to cross endothelial blood barriers in the dermis in both
directions, in (24) and out (Figure 3) of the vessel lumen.
To do this, sporozoites could use their cell traversal
capacity, which will be examined in more detail below.
However, the mutants lacking the proteins sporozoite
protein essential for cell traversal (SPECT) or SPECT2
630 Traffic 2008; 9: 627–635
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(33,34) can still cross both blood and lymphatic endothelia
in the skin (35). Cell traversal might still be involved in
crossing endothelia but depend on membrane-damaging
molecules other than SPECT/SPECT2. One such possibil-
ity is a phospholipase possessing a domain homologous to
mammalian lecithin–cholesterol acyl transferases, which is
important for the sporozoite capacity to leave the skin after
natural transmission (36), although the exact defect of the
phospholipase null mutant, that is, lack of cell traversal or
otherwise, remains unknown. Alternatively, by analogy
with the Toxoplasma tachyzoite, sporozoites might pull
on junctional molecules to transmigrate by a paracellular
route or, like leukocytes, through transcellular channels
without breaching cell plasma membranes.
Leaving the blood in the liver: which way out?
Crossing the liver sinusoidal barrier to reach hepatocytes
poses a specific problem (Figure 4). The liver sinusoids
are lined by endothelial cells and harbor resident macro-
phages, the Kupffer cells, which phagocytose particulate
and foreign materials from the portal circulation. The role
of these phagocytic cells during sporozoite passage into
the liver parenchyma has been a much debated question,
ever since the first transmission electron microscopy
(TEM) evidence that Kupffer cells might act as gates by
bridging the sinusoidal lumen and underlying hepatocytes
(37). An unresolved issue is the exact position of Kupffer
cells in the sinusoid wall. Kupffer cells are known to be
less motile than other leukocytes in the sinusoids, or even
immotile, but whether they are interspersed between
endothelial cells or instead lie on their luminal face is still
unclear.
The work from one laboratory has provided evidence
supporting the ‘gateway hypothesis’ (28,38–41), in line
with the view that Kupffer cells dwell between endothelial
cells, and proposed that Kupffer cell traversal is an
obligatory step of the parasite life cycle (42). Still, the final
demonstration by intravital imaging that sporozoites trans-
locate from the sinusoid lumen into the parenchyma
through Kupffer cells (28) has been difficult to provide, as
acknowledged by the authors themselves (41), because of
the insufficient resolution of the wide-field microscopy
used. One traditional argument against the gateway
hypothesis is the fact that clodronate, which kills Kupffer
cells and other macrophages, greatly enhances sporozoite
infection of the liver (43). However, the authors have
suggested using TEM that the clodronate-induced macro-
phage death leaves temporary gaps in the sinusoidal
barrier large enough to be used by sporozoites as artificial
gates, although too small to cause hemorrhage into the
parenchyma (42). Genetically altered mice (op/op) having
fewer Kupffer cells because of a defect in macrophage
maturation were also shown to be more resistant to
sporozoite infection (42), although the pleiotropy of the
Figure 3: A Plasmodium berghei sporozoite exiting a blood vessel in the dermis of a mouse. A) The fluorescent sporozoite glides
inside the vessel colored in red after injection of red fluorescent BSA. The time (in seconds) is indicated in the upper left part of each panel.
The intravascular sporozoite glides during the first 67 seconds (gray triangles), is suddenly displaced (yellow circle, 69 seconds), glides
again inside the vessel (green triangles), extravazates (from 448 to 465 seconds, note the sporozoite constriction pointed by the blue
arrows) before gliding in the dermis (468 to 496 seconds, red triangles until the white square). B) Maximum intensity projection of the
fluorescent sporozoite from the 69th (yellow circle) to the 496th second (white square) through the constriction (blue arrow). C) Velocity
profile of the sporozoite between the 69th and the 496th second.
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cytes to be much smaller in mutant mice, makes specific
conclusions on sporozoite translocation into the paren-
chyma uncertain.
An alternative hypothesis would placemost Kupffer cells on
the top of endothelial cells (44–46) and would assume that
traversal of Kupffer cells does not obviate the need to cross
the endothelial barrier. Kupffer cells, like dermal macro-
phages (see below), would essentially play a detrimental
role on sporozoite progression, providing a simple explana-
tion to the effect of clodronate. Traversal of Kupffer cells
would be followed by translocation across the sinusoidal
barrier, which could occur by one of the mechanisms
mentioned abovefor sporozoitesonthe way in. Inany case,
theuseofclodronateclearlydemonstratesthatKupffercells
are notimportantforsporozoite infection,regardless ofhow
sporozoites cross the barrier in their absence.
Making Sense of Host Cell Traversal:
Activating Cell Infection in the Liver Or
Escaping Phagocytosis En Route to the Liver?
In addition to being able to infect hepatocytes, that is,
penetrating them inside a PV, the Plasmodium sporozoite
can also traverse host cells, that is, glide through them. The
sporozoite cell traversal capacity was first described by
Vanderberg et al. (47) when imaging interactions between
P. berghei sporozoites and rodent peritoneal macrophages.
Among other types of interactions, sporozoites were seen
entering and exiting macrophages in a ‘needling manner’
and inducing an ‘outward flow of host cell cytoplasm at the
point ofegress’. Host cell traversalwas alsoshownto occur
withepithelialcellsand fibroblasts(48).The rolethatthiscell
traversal behavior plays in sporozoite infection in vivo,
however, remains controversial.
Because in vivo cell traversal by sporozoites was docu-
mented first in the liver parenchyma of rodent hosts
(28,48), it was presumed that cell traversal would some-
what favor hepatocyte infection (48). In fact, it was
reported that traversing several hepatocytes was essential
to render sporozoites competent for infecting a ‘final
hepatocyte’ inside a vacuole by regulated exocytosis of
thrombosponding related anonymous protein (TRAP) (the
Toxoplasma MIC2 ortholog) and other micronemal prod-
ucts important for the moving junction (MJ) and PV
biogenesis (49). This seemed counterintuitive, though, as
TRAP-dependent gliding motility by definition precedes
any cell traversal event, and sporozoites build a MJ and
a PV to penetrate salivary gland cells in the mosquito (50).
Subsequent work suggested that cell traversal also had
an impact on the host hepatocyte (51) in that migration
through hepatocytes induced the secretion of hepatocyte
growth factor from wounded cells, which in turn activated
MET-dependent signals in neighboring infected cells.
These signals were first proposed to be essential for
parasite differentiation by reorganizing actin around the
PV (51) and later to act mainly by preventing apoptosis in
the infected cell (52). A model thus emerged in which
hepatocyte traversal would enable the two subsequent
steps of the parasite life cycle: hepatocyte infection, by
activating the sporozoite, and parasite development, by
priming the hepatocyte (53–56).
These conclusions, however, were questioned by the
discovery of two proteins involved in sporozoite cell
Figure 4: How does the Plasmodium sporozoite leave the lumen of the liver sinusoid and invade a hepatocyte inside a PV? It is
still unclear whether Kupffer cells are embedded in the sinusoidal barrier (A) or sit on the top of endothelial cells (B). If (A) occurs, then
traversalof Kupffercells(either bytranscytosis, i.e., involving sporozoite entryinsidea PV followedbyescapefromthecell, orbydisrupting
the Kupffer cell membranes and migrating through the cell) would be sufficient for crossing the sinusoidal barrier. If (B) occurs, then the
sporozoite may, after traversing Kupffer cells, cross the endothelial barrier either by a paracellular route (2) or by traversing endothelial cells
(3). Once in the parenchyma, the sporozoite traverses several hepatocytes (4) before invading a final one inside a PV (5), the only niche
where a sporozoite can fully develop (6). In two opposing views, the final invasion step is either activated by prior hepatocyte traversal or
instead constitutively available and requires inhibition of cell traversal.
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containing a typical membrane-attack/perforin-like domain
found in pore-forming proteins. Inactivation in P. berghei of
either spect (33) or spect2 (34) abrogates the sporozoite
capacity to traverse but not to infect or develop inside,
hepatocytes, thus arguing against both aspects of the
above model. Intravital imaging recently showed that spo-
rozoite mutants are immobilized and destroyed by phago-
cytic leukocytes in the dermis (35), in line with previous
work providing indirect evidence for a role of cell traversal in
resistance to Kupffer cells (33,34), thus supporting the view
that cell traversal is primarily a means of defense against
host phagocytic leukocytes. Once the sporozoite has pen-
etrated the liverparenchyma, however,the traversalactivity
seems dispensable, and even harmful, to hepatocyte
infection. Indeed, infection of primary hepatocytes is con-
stitutive (completed in a few minutes) in the absence of cell
traversal but is retarded in its presence (35). Therefore, the
phenotype of the cell traversal-deficient mutants suggests
the model that the cell traversal activity must be ‘on’ during
the sporozoite journey to hepatocytes but should be
switched off upon arrival to destination, hepatocyte infec-
tion resulting from repression of the traversal activity
rather than from activation of the infection capacity.
Interestingly, a recent study proposes that the sporozoite
uses the sulfation level of heparan sulfate proteoglycans
(HSPG) on the surface of host cells as a Global Positioning
System (57), helping it to decide whether to continue to
migrate (through cells expressing under-sulfated HSPG) or
to switch to invasion inside a vacuole (into cells covered
with highly sulfated HSPG, primarily hepatocytes). This
signal might thus promote sporozoite invasion upon cell
contact, but whether it is also involved in arresting cell
traversal remains unknown. Another recent study (58)
shows that incubation of sporozoites in potassium almost
abolishes cell traversal, suggesting that traversing cells
might reduce the traversal activity itself. More work is
needed for understanding what triggers the formation of
the MJ and PV and the inhibition of cell traversal as well as
the fine-tuning of these processes.
Conclusions
It is clear that the Toxoplasma tachyzoite and the
Plasmodium sporozoite, typically presented as exchange-
able models, share common mechanisms to glide in host
tissues and invade host cells inside a vacuole and possibly
also common means of crossing cellular barriers. However,
one key distinctive feature between the two zoites is the
ability or inability to traverse host cells, which determines
the different ways in which they interact with leukocytes
and control their fate. During their life, both zoites rapidly
encounterhostilephagocytes inthe intestinallamina propria
for the newly formed tachyzoite and in the dermis for the
freshly inoculated sporozoite. While the tachyzoite invades
and hijacks leukocytes to locomote in the host, the sporo-
zoite glides through them to find its way to the appropriate
niche. The sporozoite also exhibits a vigorous gliding
phenotype to go along with its brute-force strategy.
There are many questions left unanswered on how the
Toxoplasma tachyzoite and the Plasmodium sporozoite
reach their final niche. There is accumulating evidence that
shuttle leukocytes play a major role in the dissemination of
Toxoplasma tachyzoites, and investigating the mecha-
nisms by which they subvert and pilot the host cell to
destination promises to yield fascinating insights. How-
ever, the infectious potential of free tachyzoites is still
unclear. They might target specific sites, including the
placenta, and indeed, specific destinations in the host
might be determined by the engagement of distinct
host–parasite interactions. The journey of the Plasmodium
sporozoite is also riddled with uncertainties. The impact on
the host immune system of those sporozoites that do not
reach a hepatocyte (59), most crucially in human infec-
tions, is a pressing question. How sporozoites cross
endothelia, whether Kupffer cells act as gates or sieves
in the process and how they switch from a traversal to an
infective mode are still open questions. Because Apicom-
plexa zoites have multiple ways to interact with and cross
cellular barriers and end up in different tissues in their
hosts, the next challenge will be to recognize the relative
contributions of each possible route of infection in order to
fully grasp the versatility of these parasites and the
complexity of the infections they cause. In that endeavor,
in vivo imaging approaches will be crucial by examining
host–parasite interactions in a natural context and in
a quantitative manner.
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